• 08-FEB-2013


IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

IBM Watson Hard At Work

IBM (NYSE: IBM), WellPoint, Inc. (NYSE: WLP) and Memorial Sloan-Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence based medicine.

For more than a year, IBM has partnered separately with WellPoint and Memorial Sloan-Kettering to train Watson in the areas of oncology and utilization management. During this time, clinicians and technology experts spent thousands of hours "teaching" Watson how to process, analyze and interpret the meaning of complex clinical information using natural language processing, all with the goal of helping to improve health care quality and efficiency.